Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed480%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Use of Faecal Calprotectin to Predict Enteropathy of the Preterm Neonates

NCT02010268
unknown

Polish Microbiome Map

NCT04169867
completednot_applicable

Evaluation of New Method for Measuring Stool Consistency

NCT03188302
completed

Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants

NCT00655187
completed

Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania

NCT01253967

Clinical Trials (5)

Showing 5 of 5 trials
NCT02010268Not Applicable

Use of Faecal Calprotectin to Predict Enteropathy of the Preterm Neonates

Completed
NCT04169867

Polish Microbiome Map

Unknown
NCT03188302Not Applicable

Evaluation of New Method for Measuring Stool Consistency

Completed
NCT00655187

Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants

Completed
NCT01253967

Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5